Furthermore, our findings reveal that APOE ε4-induced brain organoids with mutant APP overexpression accurately recapitulate the acceleration of AD-related pathologies, offering a more physiologically relevant and patient-specific model of AD. This evidence concerns the gene APP and Alzheimer disease.